JEE Advanced 2025 Results and Toppers List: Rajit Gupta from IIT Delhi zone tops the exam; Check names of toppers hereJEE Advanced 2025 Toppers: Rajit Gupta from IIT Delhi zone has topped the JEE Advanced 2025, securing AIR 1 with 332 out of 360 marks. The ...
02 Jun, 2025, 10.33 AM IST
USFDA issues CRL for Bevacizumab license application moved by Viatris: Biocon"The USFDA has issued a CRL for the Biologics License Application (BLA) for Bevacizumab filed by our partner Viatris (Mylan)," a company sp...
12 Feb, 2023, 08.01 PM IST
USFDA issues CRL for proposed biosimilar Insulin-R: BioconThe CRL cites additional data required in the BLA submission and an expectation of satisfactory implementation of a corrective and preventi...
07 Jan, 2023, 03.38 PM IST
JEE-Advanced results announced; Pune boy Chirag Falor tops exam: IIT officialsA total of 43,204 candidates of the 1,50,838 who appeared in both papers 1 and 2 in JEE (Advanced) 2020 have qualified in the exam. Of the ...
05 Oct, 2020, 12.03 PM IST
Former RBI deputy governor appointed as chairman of MFI panelMembers of the steering committee include Harsh Shrivastava of MFIN, P Satish of Sa-Dhan, Srinivas Bonam of IndusInd Bank and Sonia Krishna...
29 Nov, 2019, 11.37 AM IST
Stock pick of the week: Why analysts are bullish on Glenmark Pharma despite recent price dipOut-licensing of its anti-allergic drug Ryaltris will help Glenmark save costs related to rectification, sales force and promotional activi...
08 Jul, 2019, 06.30 AM IST
Glenmark Pharma says USFDA has issued CRL for RyaltrisThe CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing faciliti...
22 Jun, 2019, 03.49 PM IST
38,705 clears JEE (Advanced) 2019; Kartikey Gupta tops the exam14 Jun, 2019, 02.47 PM IST
Biocon rallies over 7% as USFDA issues CRL for proposed biosimilarThis product is a part of the biosimilars portfolio being developed jointly by Biocon and Mylan, the company said in a BSE filing.
10 Oct, 2017, 04.05 PM IST
USFDA issues CRL for proposed biosimilar Pegfilgrastim: BioconThe company said it does not expect the CRL to impact the timing of the launch of biosimilar Pegfilgrastim in the US market.
10 Oct, 2017, 02.19 PM IST
Biocon gets CRL from USFDA for anti-cancer drugThe company, however, said it does not expect this CRL to impact the commercial launch timing of biosimilar Pegfilgrastim in the US.
10 Oct, 2017, 11.59 AM IST
USFDA subjects SPARC Xelpros nod to 'satisfactory resolution'Earlier this month, Sun Pharma said the US health regulator had made nine observations after the completion of inspection of its Halol faci...
22 Dec, 2016, 12.03 PM IST
SPARC advances over 6% on getting USFDA's CRL for XelprosOn BSE, 1.14 lakh shares were traded on the counter in the first half an hour, compared with an average daily volume of 42,000 shares in th...
22 Dec, 2016, 10.49 AM IST
Expect delay in start of royalty from 2 new drugs: SPARCSun Pharma Advanced Research Company (SPARC) expects further delay in start of royalty income from its two new drug applications, including...
31 Dec, 2015, 08.50 PM IST
USFDA denies approval for SPARC's anti-glaucoma eyedropSun Pharma Advanced Research Company (SPARC) today said the US health regulator has not approved its new drug application for anti-glaucoma...
01 Aug, 2015, 12.42 PM IST
- Tata's CRL joins hands with Yahoo
Tata's Computational Research Laboratories (CRL) has joined hands with Internet giant Yahoo! for research in cloud computing technologies t...
25 Mar, 2008, 04.45 PM IST
- Tata's supercomputer Eka is fastest in Asia
The Tata Group has developed the fourth-fastest supercomputer in the world and the fastest in Asia. Thinking of buying a new computer?
14 Nov, 2007, 02.25 PM IST